Stifel Financial
CMPX icon

Stifel Financial’s Compass Therapeutics CMPX Stock Holding History

Stifel Financial’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.1K Sell
14,211
-13,286
-48% -$39.2K ﹤0.01% 3677
2026
Q1 		$145K Buy
27,497
+3,524
+15% +$20.3K ﹤0.01% 3496
2025
Q4 		$129K Buy
+23,973
New +$111K ﹤0.01% 3458
2023
Q4 		– Sell
-15,000
Closed -$29.6K – 3341
2023
Q3 		$29.6K Hold
15,000
– – ﹤0.01% 3222
2023
Q2 		$47.7K Buy
+15,000
New +$47.1K ﹤0.01% 3243

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Stifel Financial's CMPX Position: Q2 2026 in Review

Stifel Financial reduced its Compass Therapeutics (CMPX) stake by 48% in Q2 2026, selling an estimated $39.2K and leaving 14,211 shares worth $31.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3677.

Stifel Financial first reported a position in CMPX in Q2 2023 and has held it in 5 quarters since. The position peaked at $145K in Q1 2026. 216 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Stifel Financial held 14,211 shares of Compass Therapeutics worth $31.1K as of Q2 2026.
  • Stifel Financial sold 13,286 Compass Therapeutics shares in Q2 2026, an estimated $39.2K.
  • Compass Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #3677 holding.
  • Stifel Financial first reported a position in Compass Therapeutics in Q2 2023 and has held it in 5 quarters since.
  • Stifel Financial's Compass Therapeutics position peaked at $145K in Q1 2026.
  • 216 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.